Daniel Karp insider trades

Open-market stock purchases and sales by Daniel Karp, Executive VP, Corp. Dev. at Organon & Co, from SEC Form 4 filings since Jul 2, 2018.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +67%.

Recent trades

DateStockTradeValue
Mar 31, 2026OGN Organon & CoSold (not open market)$20.3K
Mar 31, 2026OGN Organon & CoSold (not open market)$12K
Mar 31, 2026OGN Organon & CoBought (not open market)—
Mar 31, 2026OGN Organon & CoBought (not open market)—
Mar 31, 2026OGN Organon & CoBought (not open market)—
Mar 29, 2026OGN Organon & CoSold (not open market)$26K
Mar 29, 2026OGN Organon & CoBought (not open market)—

Companies traded

  • OGN Organon & Co: 1 buy, last Mar 31, 2026
  • BIIB Biogen Inc: other filings, last Feb 12, 2020

Get free alerts when Daniel Karp files a new trade →